African Vaccine Sovereignty: Wits Research Accelerates | AcademicJobs
Explore how Wits University's AGTRU is driving Africa's vaccine independence through mRNA platforms, viral mimics, and green lipids, amid the 60% local production goal by 2040.
No reviews yet. Be the first to rate Betty!
Betty Maepa is an Associate Professor in the Antiviral Gene Therapy Research Unit at the University of the Witwatersrand. She holds a BSc, BScHons, MSc and PhD, all awarded by the University of the Witwatersrand. Her doctoral research, completed in 2009, involved the characterisation of Mycobacterium tuberculosis ribonucleotide reductase genes as potential targets for novel anti-tuberculosis drugs.
Professor Maepa joined the Antiviral Gene Therapy Research Unit in 2009. Her research focuses on the development and application of viral vectors for the delivery of gene therapeutics and vaccines targeting hepatitis B virus. She contributes to the unit’s work on antiviral gene therapy approaches within the School of Pathology in the Faculty of Health Sciences. Her professional email address is publicly listed on the university website.
Explore how Wits University's AGTRU is driving Africa's vaccine independence through mRNA platforms, viral mimics, and green lipids, amid the 60% local production goal by 2040.